{"id":"https://openalex.org/W2143917543","doi":"https://doi.org/10.18433/j3b88v","title":"A study of intestinal absorption of bicyclol in rats: active efflux transport and metabolism as causes of its poor bioavailability","display_name":"A study of intestinal absorption of bicyclol in rats: active efflux transport and metabolism as causes of its poor bioavailability","alternate_titles":[],"publication_year":2008,"publication_date":"2008-09-06","ids":{"openalex":"https://openalex.org/W2143917543","doi":"https://doi.org/10.18433/j3b88v","mag":"2143917543","pmid":"https://pubmed.ncbi.nlm.nih.gov/18801310"},"language":"en","primary_location":{"id":"doi:10.18433/j3b88v","doi":"https://doi.org/10.18433/j3b88v","is_oa":true,"landing_page_url":"https://doi.org/10.18433/j3b88v","pdf_url":"https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/download/1020/3304","source":{"id":"https://openalex.org/S166796225","display_name":"Journal of Pharmacy & Pharmaceutical Sciences","issn_l":"1482-1826","issn":["1482-1826"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313003","host_organization_name":"Canadian Society for Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4310313003"],"host_organization_lineage_names":["Canadian Society for Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy &amp; Pharmaceutical Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2143917543"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/download/1020/3304","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113854560","display_name":"Wei Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Tan","raw_affiliation_strings":["Department of New Drug Development, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100050, People's republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of New Drug Development, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100050, People's republic of China","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100334164","display_name":"Hui Chen","orcid":"https://orcid.org/0000-0002-1633-6348","observed_orcids":["https://orcid.org/0000-0002-1633-6348"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hui Chen","raw_affiliation_strings":["Department of New Drug Development, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100050"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of New Drug Development, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100050","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100614803","display_name":"Jinping Hu","orcid":"https://orcid.org/0000-0003-2382-2034","observed_orcids":["https://orcid.org/0000-0003-2382-2034"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jinping Hu","raw_affiliation_strings":["Department of New Drug Development, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100050"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of New Drug Development, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100050","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100689299","display_name":"Yan Li","orcid":"https://orcid.org/0000-0002-2781-2119","observed_orcids":["https://orcid.org/0000-0002-2781-2119","https://orcid.org/0009-0004-8640-8628"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yan Li","raw_affiliation_strings":["Department of New Drug Development, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100050","Institute of Materia Medica,Chinese Academy of Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of New Drug Development, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100050","institution_ids":["https://openalex.org/I200296433"]},{"raw_affiliation_string":"Institute of Materia Medica,Chinese Academy of Medical Sciences","institution_ids":["https://openalex.org/I200296433"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I200296433"],"apc_list":{"value":2200,"currency":"USD","value_usd":2200},"apc_paid":{"value":2200,"currency":"USD","value_usd":2200},"fwci":0.3411,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.64043193,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"11","issue":"3","first_page":"97","last_page":"97"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.021299999207258224,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bicyclol","display_name":"bicyclol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/intestinal-absorption","display_name":"intestinal absorption","score":0.9449999928474426},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8410000205039978},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9350000023841858},{"id":"https://openalex.org/keywords/cyp3a","display_name":"CYP3A","score":0.8560000061988831},{"id":"https://openalex.org/keywords/efflux-transport","display_name":"efflux transport","score":0.7440000176429749},{"id":"https://openalex.org/keywords/intestinal-metabolism","display_name":"intestinal metabolism","score":0.8320000171661377},{"id":"https://openalex.org/keywords/troleandomycin","display_name":"troleandomycin","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/caco-2-cell-monolayers","display_name":"Caco-2 cell monolayers","score":0.8180000185966492},{"id":"https://openalex.org/keywords/midazolam","display_name":"midazolam","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.8511037826538086},{"id":"https://openalex.org/C11824378","wikidata":"https://www.wikidata.org/wiki/Q5014970","display_name":"CYP3A","level":4,"score":0.7935149669647217},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6864669322967529},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.6674607992172241},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6087353229522705},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.6081970930099487},{"id":"https://openalex.org/C2781071285","wikidata":"https://www.wikidata.org/wiki/Q17141320","display_name":"Intestinal permeability","level":2,"score":0.5660890340805054},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.47660937905311584},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.45086508989334106},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.332200825214386},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26401710510253906},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2593972682952881},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.24550732970237732},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15118303894996643},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.05083656311035156},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001693","descriptor_name":"Biological Transport, Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010477","descriptor_name":"Perfusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D065692","descriptor_name":"Cytochrome P-450 CYP3A Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.18433/j3b88v","doi":"https://doi.org/10.18433/j3b88v","is_oa":true,"landing_page_url":"https://doi.org/10.18433/j3b88v","pdf_url":"https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/download/1020/3304","source":{"id":"https://openalex.org/S166796225","display_name":"Journal of Pharmacy & Pharmaceutical Sciences","issn_l":"1482-1826","issn":["1482-1826"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313003","host_organization_name":"Canadian Society for Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4310313003"],"host_organization_lineage_names":["Canadian Society for Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy &amp; Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:18801310","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18801310","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:da51cb94f88f4d438178402a89799dbf","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/da51cb94f88f4d438178402a89799dbf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacy & Pharmaceutical Sciences, Vol 11, Iss 3 (2008)","raw_type":"article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.504.220","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.504.220","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://ejournals.library.ualberta.ca/index.php/JPPS/article/download/1020/3304/","raw_type":"text"}],"best_oa_location":{"id":"doi:10.18433/j3b88v","doi":"https://doi.org/10.18433/j3b88v","is_oa":true,"landing_page_url":"https://doi.org/10.18433/j3b88v","pdf_url":"https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/download/1020/3304","source":{"id":"https://openalex.org/S166796225","display_name":"Journal of Pharmacy & Pharmaceutical Sciences","issn_l":"1482-1826","issn":["1482-1826"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313003","host_organization_name":"Canadian Society for Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4310313003"],"host_organization_lineage_names":["Canadian Society for Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy &amp; Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320335777","display_name":"National Key Research and Development Program of China","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2143917543.pdf","grobid_xml":"https://content.openalex.org/works/W2143917543.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W22518151","https://openalex.org/W56776561","https://openalex.org/W1515913184","https://openalex.org/W1574019439","https://openalex.org/W1892194801","https://openalex.org/W1979196526","https://openalex.org/W1997211805","https://openalex.org/W2000369238","https://openalex.org/W2002044083","https://openalex.org/W2017411996","https://openalex.org/W2025048009","https://openalex.org/W2039603044","https://openalex.org/W2044148793","https://openalex.org/W2044814201","https://openalex.org/W2049328486","https://openalex.org/W2059843617","https://openalex.org/W2061155379","https://openalex.org/W2078394995","https://openalex.org/W2085815144","https://openalex.org/W2089071514","https://openalex.org/W2168858467","https://openalex.org/W2347301293","https://openalex.org/W2352554250","https://openalex.org/W2371030845","https://openalex.org/W2387642290"],"related_works":["https://openalex.org/W2009740943","https://openalex.org/W2295710313","https://openalex.org/W2350968553","https://openalex.org/W1576473153","https://openalex.org/W1971182486","https://openalex.org/W2132110939","https://openalex.org/W2085815144","https://openalex.org/W2355970644","https://openalex.org/W1986079332","https://openalex.org/W1980510434"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"determine":[2],"the":[3,13,104],"possible":[4],"mechanism":[5],"of":[6,9,16,39,66,68,84,93,101,107,119,129,145],"poor":[7,143],"bioavailability":[8,144],"bicyclol,":[10],"and":[11,20,31,41,62,76,95,139,154],"clarify":[12],"respective":[14],"contribution":[15,164],"P-":[17],"glycoprotein":[18],"(P-gp)":[19],"Cytochrome":[21],"3A":[22],"(CYP3A).":[23],"METHODS:":[24],"Rat":[25],"in":[26,54,109,121,131,158],"situ":[27],"single-pass":[28],"intestinal":[29,48],"perfusion":[30],"Caco-2":[32,132],"cell":[33],"monolayer":[34,133],"model":[35],"with":[36,160],"selective":[37],"inhibitors":[38,67],"CYP3A":[40,71,77,157,161],"P-gp":[42,69,75,151],"were":[43],"employed.":[44],"RESULTS:":[45],"In":[46],"rat":[47],"perfusion,":[49],"bicyclol":[50,108,120,130,146],"(50":[51],"microM)":[52],"appearance":[53],"mesenteric":[55,110],"blood":[56,111],"(Pblood)":[57],"was":[58,89,112,134],"increased":[59,96,113],"3,":[60],"12":[61],"16-fold":[63],"after":[64,91,99],"addition":[65,92,100],"(LSN335984),":[70],"(troleandomycin,":[72],"TAO)":[73],"or":[74],"(Cyclosporin":[78],"A,":[79],"CsA),":[80],"respectively,":[81],"whereas":[82],"permeability":[83,127],"midazolam":[85],"(CYP3A":[86],"substrate":[87],"only)":[88],"unchanged":[90],"LSN335984":[94,138],"5":[97],"fold":[98],"TAO.":[102],"Moreover,":[103],"cumulative":[105],"amount":[106],"at":[114],"concentration":[115],"range":[116],"10-100":[117],"microM":[118],"perfusate.":[122],"The":[123,142],"basolateral":[124],"to":[125,150],"apical":[126],"value":[128],"significantly":[135],"deceased":[136],"by":[137,156],"CsA.":[140],"CONCLUSIONS:":[141],"is":[147],"mostly":[148],"due":[149],"mediated":[152],"efflux":[153],"metabolism":[155],"intestine,":[159],"making":[162],"more":[163],"than":[165],"P-gp.":[166]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2143917543","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
